Altre lingue Intelligent Bio Solutions Inc.

Azioni

INBS

US36151G6008

Prezzo di chiusura Nasdaq Altri mercati azionari 00:00:00 02/07/2024			Variaz. 5gg	Var. 1 gen.
1,84 ^USD	+0,38%		+3,95%	-54,62%

18/06	Intelligent Bio Solutions Inc. inizia il dosaggio e il campionamento dei soggetti per lo studio farmacocinetico (PK) FDA 510(k) per la sua tecnologia di screening farmacologico con impronte digitali intelligenti	CI
12/06	Intelligent Bio Solutions aggiunge un importante fornitore europeo di soluzioni di trasporto e infrastrutture al crescente numero di clienti che adottano la tecnologia di screening delle impronte digitali.	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Intelligent Bio Solutions Completes In-Clinic Portion of Pharmacokinetic Study Part of 510(k) Pathway for Approval and Commences Review of Results	01/07
Intelligent Bio Solutions Completes In-Clinic Portion of Pharmacokinetic (PK) Study Part of 510(k) Pathway for Approval & Commences Review of Results	28/06
Intelligent Bio Solutions Expands Presence in the UK Retail Sector with Major Account Acquisitions	27/06
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Rises in After-Hours Trading Following Major UK Contracts and FDA Progress	27/06
Kaival Brands Innovations Group (NASDAQ: KAVL) Secures $6M in Public Offering, Stock Surges Watch VTAK, OCGN, DYAI, INBS	27/06
Intelligent Bio Solutions Broadens UK Customer Base by Securing Two Key Accounts with Over 70 Locations and Over 15,000 Employees in the Warehouse and Logistics Sector	20/06
INTELLIGENT BIO SOLUTIONS BEGINS SUBJECT DOSING AND SAMPLING FOR FDA 510(K) PHARMACOKINETIC STUDY FOR ITS INTELLIGENT FINGERPRINTING DRUG SCREENING TECHNOLOGY	19/06
Catheter Precision (NYSE American: VTAK) Announces New LockeT Purchase Order and Expands Sales Team Amid Surge in Trading Volume	19/06
Intelligent Bio Solutions Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening Technology	18/06
Intelligent Bio Solutions Inc. Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening Technology	18/06
Intelligent Bio Solutions Implements Strategic Reorganization Plan to Support Global Growth Initiatives	13/06
Intelligent Bio Solutions Adds Major European Transport and Infrastructure Solutions Provider to Growing Number of Accounts Adopting Fingerprint Drug Screening Technology	12/06
Intelligent Bio Solutions Adds Major European Transport and Infrastructure Solutions Provider to Growing Number of Accounts Adopting Fingerprint Drug Screening Technology	12/06
Intelligent Bio Solutions Inc. Announces Board Changes	07/06
Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Conference on June 12-13, 2024	06/06
Nasdaq Stocks Soaring to the Top with Strategic Splits: NVDA, INBS, JAGX, SINT, GWAV	05/06
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Advancing US FDA Process, Featured Among Top Health Care Movers	03/06
Intelligent Bio Solutions Starts Subject Screening for Drug Testing System Study	29/05
Intelligent Bio Solutions Successfully Completes Recruitment and Begins Subject Screening for FDA 510(k) Pharmacokinetic (PK) Study	29/05
Intelligent Bio Solutions Inc. Completes Recruitment and Begins Subject Screening for FDA 510(K) Pharmacokinetic Study	29/05

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Intelligent Bio Solutions Inc.

Azioni

INBS

US36151G6008

Altre lingue

Filtri